Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
18 August, 2017 14:27 IST
Alembic Pharma gets USFDA's tentative nod for Vilazodone HCl tablets
Source: IRIS | 19 Apr, 2017, 11.14AM
Comments  |  Post Comment

Alembic Pharmaceuticals has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Vilazodone Hydrochloride Tablets, 10mg, 20mg and 40mg.

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Viibryd Tablets, 10 mg, 20mg and 40mg, of Forest Labs LLC. Vilazodone Hydrochloride Tablets are indicated for the treatment of Major Depressive Disorder (MDD). Alembic is currently in litigation with Forest Labs LLC in District Court of Delaware and has stipulated to stay the case in view of the ongoing settlement discussions.

Vilazodone Hydrochloride Tablets have an estimated market size of USD 340 million for twelve months ending December 2016 according to IMS.

Alembic now has a total of 54 ANDA approvals (47 final approvals and 7 tentative approvals) from the USFDA.

Shares of the company gained Rs 12, or 1.97%, to trade at Rs 621.95. The total volume of shares traded was 7,783 at the BSE (11.05 a.m., Wednesday).



Alembic Pharmaceuticals Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Sector
Telecommunications sector to generate 30 lakh jobs by 2018: Assocham-KPMG - 18-Aug-2017 12:20
Vishal Sikka resigns as MD & CEO of Infosys - 18-Aug-2017 12:12
HDFC Bank revises interest rates on saving bank accounts - 18-Aug-2017 11:42
Power Grid to invest Rs 19.31 bn for power transmission related project - 18-Aug-2017 11:30
Infosys in association with ATP unveils new PlayerZone - 18-Aug-2017 11:26
Raymond acquires Ansel's stake in JV entity 'JK Ansell' - 18-Aug-2017 10:24
Piramal Enterprises' arm acquires 100% stake in Context Matters - 17-Aug-2017 10:03
Karnataka Bank ventures into social media presence - 17-Aug-2017 10:00
Majesco expands strategic partnership with tier one insurer - 17-Aug-2017 09:54
L&T to divest entire stake in L&T Cutting Tools for Rs 1.74 bn - 17-Aug-2017 09:46
EESL and IOCL, BPCL & HPCL sign MOUs for distribution of energy efficient appliances - 17-Aug-2017 08:46
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer